We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Biota Pharmaceuticals Announces Results of Strategic and Operational Review

News   Apr 18, 2013

 
Biota Pharmaceuticals Announces Results of Strategic and Operational Review
 
 
 

RELATED ARTICLES

Emerging Strategies for Treating Opioid-use Disorder

News

Anti-opioid immunopharmacotherapies (e.g., conjugate vaccines) that sequester drug peripherally, preventing opioids from reaching targeted receptors in the brain, have recently emerged as promising therapeutics.

READ MORE

New Imaging Tools that Trace Key Breast Cancer Enzymes May Help Guide Therapies

News

A set of emerging diagnostic tools may help identify breast cancer patients who are most likely to benefit from therapies that target important enzymes fueling a range of subtypes, including BCRA-mutated and triple negative cancers.

READ MORE

Cancer Vaccine Progress: Potentially Rich Source of Tumor Specific Antigens Identified

News

The immunogenicity and efficacy of tumor specific antigen vaccination for select antigens has been validated in mouse models of cancer. The researchers believe that clinical trials for human cancer vaccines could start within the next 2-3 years.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE